Significant Decreasing Incidence of Encapsulating Peritoneal Sclerosis in the Dutch Population of Peritoneal Dialysis Patients. Issue 2 (March 2017)

• Record Type: Journal Article
• Authors: Betjes, Michiel G.H.; Habib, Sayed M.; Boeschoten, Els W.; Hemke, Aline C.; Struijk, Dick G.; Westerhuis, Ralph; Abrahams, Alferso C.; Korte, Mario R.
• Is Part Of: Peritoneal dialysis international. Volume 37:Issue 2(2017)
• Page Start: 230
• Page End: 234
• Publication Date: 2017-03
• Subjects: Encapsulating peritoneal sclerosis -- peritoneal dialysis -- registry -- tamoxifen; Peritoneal dialysis -- Periodicals; Continuous ambulatory peritoneal dialysis -- Periodicals; 617.461059
• DOI: 10.3747/pdi.2016.00109
• Languages: English
• ISSNs: 0896-8608

Abstract

The Dutch Encapsulating Peritoneal Sclerosis (EPS) Registry was started in 2009. Cases were identified by contacting all Dutch nephrologists twice yearly. The predefined criteria for EPS allowed for inclusion of patients with diagnosed and suspected EPS. Cases registered between January 2009 and January 2015 were analyzed with follow-up until September 2015. Fifty-three EPS cases were identified, of which 28.3% were post-transplantation EPS cases. Fourteen patients were initially categorized as suspected EPS, of whom 13 developed EPS. A remarkable 6-fold decrease in the yearly incidence of EPS was observed, from 0.85% in 2009 to 0.14% in 2014. This decrease could not be explained by a decrease in the number of PD patients or average duration of PD treatment in this period. Two-year survival of EPS patients was 52%. The use of tamoxifen and surgical interventions increased significantly over the years. Tamoxifen-treated cases showed a trend to better patient survival and post-transplantation EPS had a significantly favorable outcome. In conclusion, the incidence of EPS has declined significantly in the Netherlands from 2009 to 2014.